Abstract: A hybrid electric vehicle includes an engine, a first motor directly connected to the engine, an engine clutch, a second motor selectively connected to the first motor through the engine clutch, a transmission directly connected to the second motor, a transmission controller configured to determine whether the transmission needs to be shifted, and a hybrid controller configured to compare a target torque reduction with intervention limits of the first and second motors when the engine clutch is in a locked-up state, to set torque reduction amounts of the engine, the first motor, and the second motor, respectively, and to output a torque command for controlling the torques of the engine, the first motor, and the second motor, respectively.

Abstract: Discussed is a battery module that may include a battery cell assembly including a first battery cell assembly and a second battery cell assembly in which a plurality of battery cells are stacked, respectively; an upper frame that houses an upper surface and opposite side surfaces of the battery cell assembly and is opened in front and rear surfaces; a lower frame that houses a lower surface and the opposite side surfaces of the battery cell assembly and is opened in front and rear surfaces; and end plates that are respectively located on a surface that is adjacent to an outer side from among front and rear surfaces of the first battery cell assembly and a surface that is adjacent to an outer side among front and rear surfaces of the second battery cell assembly, wherein the first battery cell assembly and the second battery cell assembly are arranged separately in a direction facing each other, and wherein the upper frame includes a material having a melting point higher than a melting point of a material co

Abstract: Disclosed are a novel coronavirus-derived receptor-binding domain variant having reduced ACE2-binding affinity, a fusion protein comprising the same, and the use thereof. It is possible to overcome the drawbacks of conventional vaccines using the coronavirus spike protein or receptor-binding domain thereof, wherein the reduced ACE2 expression due to binding to ACE2 and negative feedback may lead to side effects of the lungs or heart, and in particular, may be fatal to patients suffering from underlying diseases of the lungs or heart. In particular, the fusion protein constructed by fusing the coronavirus receptor-binding domain with the Fc domain is imparted with a greatly improved in-vivo half-life, and has superior efficacy by further combining N protein, M protein, ORF protein, or the like of SARS-CoV-2 therewith through additional modification and thus is highly applicable to a multivalent immunogenic composition.

Abstract: The present invention relates to a novel black garlic extract using garlic bulbs separated into six bulbs as a raw material instead of conventional whole garlic and a preparation method thereof. There is an excellent effect of providing a novel black garlic extract with various functionalities of high sweetness and high viscosity and improved flavor and reddish brown color as well as induce high-concentration conversion of 10 times or more to a S-allyl-cysteine compound in which a functional ingredient of raw garlic having antioxidation, reduction in blood cholesterol, improved liver function, and enhanced blood pressure is present in a small amount of 10 ppm or less by maximizing conversion of starch into reducing sugar for most preferably 15 days in a 90% to 100% saturated steam state and a liquefied enzymatic action temperature of 75° C. to 80° C. or lower without separate enzyme addition, and optimizing the action of proteases.

Abstract: An electroluminescent display device includes a substrate including a first pixel column and a second pixel column that respectively include first pixels and second pixels arranged in a first direction and respectively have a first width and a second width in a second direction, wherein the second pixel column is positioned in the second direction from the first pixel column, and the second width is greater than the first width; a light emitting diode in each first pixel and each second pixel and including a first electrode, a light emitting layer and a second electrode; a first bank positioned between adjacent first pixels and between adjacent second pixels and covering an edge of the first electrode; a second bank positioned between the first and second pixel columns; and a first partition wall across the second pixel column along the first direction and positioned on the first electrode.

Abstract: A vehicle seatback folding device includes: a cushion bracket; a back side frame rotating on the cushion bracket; a spring mounting bracket coupled to rotate integrally with the back side frame around a hinge-coupling part; a return spring for applying, to the back side frame, elastic restoring force for rotating the back side frame in the folding direction of a seatback; and a reverse spring supported in a state in which a first end portion is caught by the spring mounting bracket and a second end portion is caught by a first spring support end.

Abstract: A shift control method of a hybrid electric vehicle includes: determining a speed control torque based on a result of comparing a speed of an input end of a transmission with a target speed of the input end of the transmission according to a shift signal; distributing the speed control torque to a second motor connected directly to the input end of the transmission; and distributing a residual speed control torque to a first motor connected selectively to the second motor through an engine clutch based on whether the engine clutch is locked up when the speed control torque is greater than a charging limit torque of the second motor.

Abstract: The present inventive concept relates to a deposition system including: a deposition device having a chamber, a seating plate located inside the chamber to seat a wafer, a magnet coupled to the underside of the seating plate, and a mask assembly located inside the chamber; and a transfer device having a load lock chamber for accommodating the wafer, an arm member for transferring the wafer from the load lock chamber to the seating plate, and a fourth driving module for moving the arm member, wherein the deposition device includes a first driving module for moving the magnet and the seating plate, a second driving module coupled to the first driving module to move the magnet, a third driving module for moving the wafer, and a control module for controlling the first driving module, the second driving module, the third driving module, and the fourth driving module.

Abstract: Each of memory blocks of a nonvolatile memory device includes a memory cell region including first metal pads, first memory cells of a first portion of pillar, and second memory cells of a second portion of the pillar, and a peripheral circuit region including second metal pads, a row decoder, and a page buffer. When performing program operations based on consecutive addresses at a memory block selected from the memory blocks, the nonvolatile memory device sequentially completes first program operations of non-adjacent memory cells not adjacent to a boundary of the first portion and the second portion from among the first and second memory cells and then completes a second program operation of an adjacent memory cell adjacent to the boundary. The peripheral circuit region is vertically connected to the memory cell region by the first metal pads and the second metal pads directly.

Abstract: Disclosed herein are an immersive image encoding/decoding method and apparatus, and a method for transmitting a bitstream generated by the immersive image encoding method. An immersive image encoding method according to the present disclosure may include: generating geometry atlases for an immersive image; aligning the geometry atlases to make an alignment height of the geometry atlases correspond to a height of a texture atlas; and generating a geometry bitstream by encoding the aligned geometry atlases.

Abstract: An adapter for attaching a needle to a pump actuated vial for injection of a vaccine or drug using a syringe-type injection motion while eliminating the time-consuming preparation of the injection device. The adapter includes a spray pump device having a first end defining a luer tip and a second end configured for accessing a media reservoir to receive a metered dose of flowable media. The luer tip is configured to be secured to a needle cannula to deliver the metered dose of the flowable media received from the spray pump device.

Abstract: The stable pharmaceutical formulation according to the present disclosure comprises (A) an antibody or antigen-binding fragment thereof that binds to an interleukin-6 receptor; (B) a surfactant; (C) stabilizers; and (D) a buffer. The stable pharmaceutical formulation according to the present disclosure has a low viscosity even when it contains an antibody, especially at a high concentration, and has excellent long-term storage stability based on excellent stability under accelerated and severe conditions, and may be administered intravenously or subcutaneously.

Abstract: A stable pharmaceutical formulation according to the present disclosure contains: a recombinant fusion protein; a surfactant; a sugar or a derivative thereof; a buffer; and an isotonic agent. The stable pharmaceutical formulation according to the present disclosure has low viscosity while containing the recombinant fusion protein, may maintain excellent stability under long-term storage conditions, accelerated conditions and stress conditions, and may be administered intraocularly.

Abstract: A device for preventing rotation of a vehicle seat rail is described. The device prevents an upper rail on the center side of a vehicle from rotating when a forward load is applied to a vehicle seat, thereby preventing a lock plate from being fractured due to rotation of the upper rail.

Abstract: A rechargeable-battery cell includes: an electrode assembly including a first electrode plate, a separator, and a second electrode plate; an electrode lead portion connected to a first or second uncoated electrode portion extending from the first or second electrode plate of the electrode assembly; a sealing member through which the electrode lead portion passes; and an exterior material from which portions of the sealing member and the electrode lead portion are externally exposed and in which the electrode structure is disposed, wherein the sealing member has the same thickness as or a thickness smaller than that of the electrode assembly.

Abstract: A method includes storing, at a computing device, access granularity criteria associated with a memory area. The method further includes receiving a memory operation request requesting access to a first portion of the memory area at the first access granularity. The method further includes in response to the memory operation request satisfying the access granularity criteria, sending, from the computing device, a command to a storage device based on the memory operation request.

Abstract: The present disclosure relates to a method for producing mesenchymal stem cells from pluripotent stem cells and mesenchymal stem cells prepared by the method. The present disclosure enables mesenchymal stem cells having superior proliferation rate while having superior intrinsic biological activity to be obtained with high yield by sequentially performing three-dimensional suspension culture using pluripotent stem cells, particularly induced pluripotent stem cells (iPSCs), as starting cells and adherent culture of cell aggregates formed therethrough. The mesenchymal stem cells produced by the method of the present disclosure can be usefully used in compositions for treating bone diseases, cartilage diseases or inflammatory and autoimmune diseases owing to high differentiation efficiency into bone and cartilage and superior anti-inflammatory activity.

Abstract: The present invention relates to an extinguishing composition and comprises an extinguishing material and a capsule containing the extinguishing material, and the extinguishing material comprises calcium bromide (CaBr2).

Abstract: A stable liquid pharmaceutical formulation according to the present invention includes an antibody or antigen-binding fragment thereof, a surfactant, a sugar or a sugar derivative, a buffer, and a stabilizer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity not only when antibody content is low but also when antibody content is high, and exhibits superior long-term storage stability based on superior stability observed under accelerated conditions and harsh conditions.

Abstract: Disclosed is a vehicle seat adjustment device including a seat-cushion-tilting frame disposed on a moving rail, the moving rail being coupled to a fixed rail so as to be movable forwards and backwards, and connected to a seatback frame, a tilting device hingedly coupled to a base bracket on the moving rail and to a rear end of the seat-cushion-tilting frame to perform forward tilting of the seat-cushion-tilting frame, a locking device connected to the tilting device to lock and unlock the tilting device, and a probe rotatably disposed between the seatback frame and the tilting device, the probe including a stopper capable of being inserted into a locking groove formed in the seatback frame. Rotation of the probe is restricted when the stopper is inserted into the locking groove.